Get informed when a big investor buys or sells
+ FollowOvervalued by 82.1% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $26.40 Million |
|---|---|
| Enterprise Value | $25.96 Million |
| Earnings per Share | $-0.02 |
| Beta | 0.57 |
| Outstanding Shares | 137,565,375 |
| P/E Ratio | -8.36 |
|---|---|
| PEG | 16.42 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.69 |
| Enterprise Value to EBIT | -6.24 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.26 |
| Debt to Equity | 0.28 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Microbix Biosystems Inc. is a life sciences enterprise that invents and markets unique biological and technological innovations designed to improve human health and well-being. Operating across North America, Europe, and other internatio...